Search

Filters

Clear Filters
8:10 AM - 8:20 AM PT

184 - Growth Outcomes Following Vertebral Body Sparing Proton CSI for Pediatric Brain Tumors: A Multicenter, Combined Prospective - Retrospective Cohort Study
Speaker: Ioakeim-Ioannidou, Myrsini, MD - Massachusetts General Hospital, Boston, MA
8:20 AM - 8:30 AM PT

185 - Low Rates of Marginal Failure in Pediatric Patients Treated with Pencil Beam Scanning Proton Therapy: Results from a Single Institution Phase IV Surveillance Trial
Speaker: Roubil, John, MD - Massey Comprehensive Cancer Center, Richmond, VA
8:30 AM - 8:40 AM PT

186 - Characterizing Radiation Target Volumes and Patterns of Failure in Pediatric Neuroendocrine Tumors Using <sup>68</sup>Ga DOTA-Octreotate PET/CT
Speaker: McKone, Elizabeth, MD - Mayo Clinic Rochester, Rochester, MN
8:40 AM - 8:50 AM PT

187 - A Phase IV Surveillance Trial of Pencil Beam Scanning Proton Therapy in Children
Speaker: Lucas, John, MD, MS - St. Jude Children's Research Hospital, Memphis, TN
8:00 AM - 8:10 AM PT

188 - RC48-ADC Combined with Radiotherapy and Immunotherapy as Salvage Therapy for Advanced Solid Tumors with HER2 Expression: A Multicenter, Phase II Trial
Speaker: Xu, Meiling, MD, PhD, RT - The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu
8:10 AM - 8:20 AM PT

189 - Single-Cell RNA Sequencing to Reveal Cellular Mechanisms Driving Differential Responses to Radiotherapy Combined with Systemic Therapy and Immunotherapy in MSS Locally Advanced Rectal Cancer with vs. without Liver Metastases
Speaker: Wang, Yaqi, MD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
8:20 AM - 8:30 AM PT

190 - Single-Cell Profiling Reveals Dynamics TIME Remodeling after Neoadjuvant Radiotherapy Followed by Chemotherapy and Immune Checkpoint Blockade in pMMR/MSS LARC
Speaker: Chen, Yinan, PhD - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing
8:30 AM - 8:40 AM PT

191 - Preclinical Evaluation of First-in-Class PROTAC Survivin Degrader HMAK101 for Radiosensitization for GBM, DIPG and Brain Metastases
Speaker: Zheng, Shuhua, DO, PhD - Northwestern Feinberg School of Medicine, Chicago, IL
8:40 AM - 8:50 AM PT

192 - A Novel Therapeutic Approach Using ENO1-specific CAR-NK Cells to Target KRAS-Mutated Cancers
Speaker: Chao, K.S. Clifford, MD - China Medical University, Taiwan, Taichung, Taichung
10:45 AM - 10:55 AM PT

193 - Quality of Life Results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Speaker: Yu, James, MD, FASTRO, MHS - Dartmouth Hitchcock Medical Center, Lebanon, NH
10:55 AM - 11:05 AM PT

194 - Daily Online Adaptive Recontouring for Prostate Cancer Using 1.5 Tesla Magnetic Resonance Image Guidance (MRgRT) Improves Patient Reported Urinary Symptoms, A Prospective, International, Observational Cohort Study (NCT04075305)
Speaker: Hall, William, MD - Medical College of Wisconsin, Milwaukee, WI
11:05 AM - 11:15 AM PT

195 - Long-Term Toxicity and Patient-Reported Quality of Life after Prostate IMRT with or without Biodegradable Balloon Rectal Spacer: Analysis of a Pivotal Randomized Trial
Speaker: Song, Daniel, MD - Johns Hopkins University, Baltimore, MD